Issue: March 2017, Posted Date: 3/15/2017
Avomeen Analytical Services Announces New CEO
Analytical Services, a full-service independent analytical testing and product
development laboratory based in Ann Arbor, MI, recently announced that Mark
Harvill has been named its CEO. High Street Capital of Chicago and Avomeen
founder and retiring CEO Shri Thanedar, PhD, made the announcement.
lead Avomeen’s day-to-day activities with an emphasis on continuing the
company’s rapid growth achieved since its inception in 2010. High Street
Capital is the majority shareholder of Avomeen following the company’s
recapitalization at year-end 2016. Dr. Thanedar will continue to hold a
minority interest and serve on the company’s Board of Directors. He will work
closely with Harvill to ensure a smooth transition.
years, Avomeen has established itself as the go-to manufacturing
problem-solving company, achieving great success under Shri’s leadership,” said
Rob France, Principal of High Street Capital. “We are pleased to welcome Mark
aboard to execute the next steps in Avomeen’s progression as a national leader
in the custom product research & development space, and we look forward to
reaching new heights as we pursue our aggressive growth goals in the years
Michigander, Harvill has more than 20 years of experience in contract research
organization management, most recently serving as the Chief Operating Officer
of Clinipace Worldwide in Morrisville, NC. There he was responsible for leading
global operations in North America, Latin America, Europe, and Asia Pacific.
Prior to Clinipace Harvill served as President and Chief Operating Officer of
Paragon Biomedical in Irvine, CA. He also spent 12 years at STATPROBE in Ann
Arbor as Executive Vice President.
“Avomeen is a
thriving company, and I am excited to bring my knowledge and expertise in this
industry to Ann Arbor,” Harvill said. “I’m proud to return to my home state of
Michigan during a time of resurgence throughout the state, with the opportunity
to guide Avomeen’s dedicated chemists and formulation developers to even
greater success in product testing, development, and analytical problem
December 2010, Avomeen has asserted itself as a leader of a wide range of
services related to laboratory testing and analysis in the pharmaceutical,
medical device, polymer, cosmetic, consumer products, health & beauty, and
manufacturing industries. The company is recognized as an industry expert in
deformulation, a form of reverse engineering involving the separation, identification,
and quantitation of both the major and minor ingredients in complex
formulations, which is typically used to either troubleshoot or replicate and
modify existing products.
Avomeen Analytical Services is a fast-growing
analytical services and product development company serving multiple
industries. Avomeen has five primary divisions, including manufacturing problem
solving, product reverse engineering, custom product development,
pharmaceutical development and chemical analysis for litigation. Avomeen has
been an Inc. 5000 company 2 years in a row, a 2017 North American Growth Excellence Leadership of the Year Award
recipient for Pharmaceutical Analytical Testing Services by Frost &
Sullivan, and was named in the Top 50 Michigan Companies to Watch by Michigan
Celebrates Small Business. For more information, visit www.avomeen.com.
This record has been viewed 199 times.